Skip to main content

Clinical Trials Using Carboplatin

Review the clinical trials studying carboplatin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 201-225 of 266

Cemiplimab with or without Chemotherapy followed by Biomarker Guided De-escalated Therapy for the Treatment of Patients with HPV-related Oropharyngeal Squamous Cell Cancer, MINIMA Trial
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Personalized Treatment with Surgery, Radiation and/or Chemotherapy for Patients with Stage I-II HPV-related Squamous Cell Carcinoma of the Oropharynx
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Involved Nodal Radiotherapy versus Elective Neck Radiotherapy for the Treatment of Stage I-IVB Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Cancer, The INVERT Trial
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Pembrolizumab Plus Combination Chemotherapy before Surgery for the Treatment of Stage I Triple Negative Breast Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
Immunotherapy versus Chemoimmunotherapy Guided by Circulating Tumor DNA-Based Molecular Response for the Treatment of Stage IV Non-small Cell Lung Cancer
Status: Active
Location: 2 locations
Trastuzumab, Pertuzumab and Docetaxel With or Without Carboplatin for the Treatment of Stage II-III HER2 Positive Breast Cancer, NeoTHERa Trial
Status: Active
Location: University of Kansas Cancer Center, Kansas City, Kansas
Reduced Chemotherapy (N10) for the Treatment of High-Risk Neuroblastoma in Children
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Transoral Surgery followed by De-escalated IMRT with or without Cisplatin or Carboplatin for the Treatment of HPV-Positive Stage III, IVA, and IVB Oropharyngeal Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, Clonal Cytopenia of Undetermined Significance and Chronic Myelomonocytic Leukemia
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Evaluating Unilateral Radiation Therapy with and without Cisplatin in Treating Patients with HPV 16+ Oropharyngeal Cancer
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Durvalumab in Combination with Chemotherapy in Treating Patients with Advanced Solid Tumors, DURVA+ Trial
Status: Active
Location: National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
Response-Adaptive Chemoradiation after Induction Therapy for the Treatment of Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
RAPA-201 Therapy of Solid Tumors
Status: Active
Location: Hackensack University Medical Center, Hackensack, New Jersey
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Pegargiminase (ADI-PEG 20), Carboplatin, and Cabazitaxel for the Treatment of Aggressive Variant Metastatic Prostate Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Total Body Irradiation and Hypofractionated Radiation Therapy with Atezolizumab and Chemotherapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, TESSERACT Trial
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Durvalumab and Tremelimumab with or without Chemotherapy for the Treatment of Potentially Resectable Pleural Mesothelioma
Status: Active
Location: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Status: Active
Location: 6 locations
Split Course Adaptive Radiation Therapy and Immunotherapy with or without Chemotherapy for the Treatment of Stage IV or Locally Advanced Lung Cancer, SiCARIO Study
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee